SC
DXCM icon

Sculptor Capital’s DexCom DXCM Stock Holding History

Sculptor Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,848
Closed -$2.16M – 454
2023
Q1 		$2.07M Hold
17,848
– – 0.05% 211
2022
Q4 		$2.02M Hold
17,848
– – 0.04% 356
2022
Q3 		$1.44M Sell
17,848
-19,000
-52% -$1.61M 0.02% 554
2022
Q2 		$2.75M Sell
36,848
-6,400
-15% -$584K 0.03% 508
2022
Q1 		$5.53M Sell
43,248
-21,192
-33% -$2.32M 0.04% 405
2021
Q4 		$8.65M Buy
64,440
+28,396
+79% +$4.08M 0.07% 227
2021
Q3 		$4.93M Buy
+36,044
New +$4.55M 0.04% 332

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Sculptor Capital's DXCM Position: Q2 2023 in Review

Sculptor Capital sold out of DexCom (DXCM) in Q2 2023, closing a stake of 17,848 shares — an estimated $2.16M sold.

Sculptor Capital first reported a position in DXCM in Q3 2021 and held it in 7 quarters. The position peaked at $8.65M in Q4 2021. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • Sculptor Capital reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
  • Sculptor Capital sold 17,848 DexCom shares in Q2 2023, an estimated $2.16M.
  • Sculptor Capital first reported a position in DexCom in Q3 2021 and held it in 7 quarters.
  • Sculptor Capital's DexCom position peaked at $8.65M in Q4 2021.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Sculptor Capital's 13F filing for Q2 2023, filed 14 Aug 2023.